Nakano Akira, Hirabayashi Kenichi, Yamamuro Hiroshi, Mashiko Taro, Masuoka Yoshihito, Yamamoto Seiichiro, Ozawa Soji, Nakagohri Toshio
Department of Digestive Surgery, Tokai University Hospital, Shimokasuya 143, Isehara, Kanagawa, 259-1143, Japan.
Department of Pathology, Tokai University Hospital, Shimokasuya 143, Isehara, Kanagawa, 259-1143, Japan.
World J Surg Oncol. 2021 Mar 16;19(1):78. doi: 10.1186/s12957-021-02187-5.
Hepatocellular carcinoma (HCC) can grow in a mosaic pattern, often combined with various non-hepatocellular cells. However, HCC combined with a neuroendocrine carcinoma (NEC) component is rarely reported, and its clinical features, origin, diagnosis, and behavior have not been established. In the literature, mixed HCC-NEC tumors are categorized as either collision type or combined type, depending on their microscopic features. Here, we report a patient with a combined-type HCC-NEC tumor.
An asymptomatic 84-year-old woman was found to have a solid mass in the right lobe of the liver. Laboratory and radiologic examinations showed typical findings of HCC, including arterial-phase enhancement, and portal- and delay-phase washout. She was treated by partial laparoscopic hepatectomy of segment 5. Pathological examination showed that the tumor was predominantly HCC, partly admixed with an NEC component. A transitional zone between the HCC and NEC tissues was also observed. The tumor was finally diagnosed as a combined-type primary mixed NEC-HCC tumor. After the preoperative diagnosis, the patient underwent somatostatin receptor scintigraphy to detect the primary NEC lesion, but no accumulation was found in any other part of her body. She has been free of recurrence for 9 months since the surgery.
Mixed HCC-NEC tumors are extremely rare, and correct diagnosis requires multidisciplinary collaboration. The accumulation of further cases is needed to help understand the exact pathology, diagnosis, and treatment of this disease.
肝细胞癌(HCC)可呈镶嵌样生长,常伴有多种非肝细胞成分。然而,HCC合并神经内分泌癌(NEC)成分的报道较少,其临床特征、起源、诊断及生物学行为尚未明确。在文献中,混合性HCC-NEC肿瘤根据其微观特征分为碰撞型或合并型。在此,我们报告1例合并型HCC-NEC肿瘤患者。
一名84岁无症状女性被发现肝脏右叶有一实性肿块。实验室及影像学检查显示典型的HCC表现,包括动脉期强化及门静脉期和延迟期廓清。患者接受了腹腔镜下右肝前叶(Ⅴ段)部分切除术。病理检查显示肿瘤以HCC为主,部分混有NEC成分。还观察到HCC与NEC组织之间的移行带。该肿瘤最终被诊断为合并型原发性混合性NEC-HCC肿瘤。术前诊断后,患者接受了生长抑素受体闪烁扫描以检测原发性NEC病灶,但未在身体其他部位发现放射性浓聚。自手术以来,患者已无瘤生存9个月。
混合性HCC-NEC肿瘤极为罕见,正确诊断需要多学科协作。需要积累更多病例以帮助了解该疾病的确切病理、诊断及治疗方法。